NO162857C - Analogifremgangsmaate for fremstilling av terapeutisk aktive amidin-derivater av 2-substituert 4-fenylimidazol. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive amidin-derivater av 2-substituert 4-fenylimidazol.

Info

Publication number
NO162857C
NO162857C NO842921A NO842921A NO162857C NO 162857 C NO162857 C NO 162857C NO 842921 A NO842921 A NO 842921A NO 842921 A NO842921 A NO 842921A NO 162857 C NO162857 C NO 162857C
Authority
NO
Norway
Prior art keywords
group
substituted
alkyl
phenylimidazole
preparation
Prior art date
Application number
NO842921A
Other languages
English (en)
Other versions
NO162857B (no
NO842921L (no
Inventor
Giuseppe Bietti
Enzo Cereda
Arturo Donetti
Antonio Giachetti
Ferdinando Pagani
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of NO842921L publication Critical patent/NO842921L/no
Publication of NO162857B publication Critical patent/NO162857B/no
Publication of NO162857C publication Critical patent/NO162857C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Processing Of Solid Wastes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO842921A 1983-07-18 1984-07-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive amidin-derivater av 2-substituert 4-fenylimidazol. NO162857C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8322110A IT1206498B (it) 1983-07-18 1983-07-18 Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.

Publications (3)

Publication Number Publication Date
NO842921L NO842921L (no) 1985-01-21
NO162857B NO162857B (no) 1989-11-20
NO162857C true NO162857C (no) 1990-02-28

Family

ID=11191639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842921A NO162857C (no) 1983-07-18 1984-07-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive amidin-derivater av 2-substituert 4-fenylimidazol.

Country Status (28)

Country Link
US (1) US4649150A (no)
EP (1) EP0131973B1 (no)
JP (1) JPS6038367A (no)
KR (1) KR910000661B1 (no)
AT (1) ATE45149T1 (no)
AU (1) AU565292B2 (no)
CA (1) CA1257274A (no)
CS (1) CS244141B2 (no)
DD (1) DD232696A5 (no)
DE (1) DE3479212D1 (no)
DK (1) DK350084A (no)
ES (2) ES534375A0 (no)
FI (1) FI842432A (no)
GB (1) GB2149395B (no)
GR (1) GR79981B (no)
HK (1) HK74287A (no)
HU (1) HU193292B (no)
IL (1) IL72417A (no)
IT (1) IT1206498B (no)
NO (1) NO162857C (no)
NZ (1) NZ208920A (no)
PH (1) PH21566A (no)
PL (2) PL143732B1 (no)
PT (1) PT78935B (no)
SG (1) SG48687G (no)
SU (2) SU1322979A3 (no)
YU (2) YU43367B (no)
ZA (1) ZA845490B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888348A (en) * 1986-09-04 1989-12-19 Ciba-Geigy Corporation Substituted thioureas, isothioureas and carbodiimides
US6121260A (en) 1997-07-03 2000-09-19 Neurogen Corporation Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
BR0017025A (pt) 1999-12-16 2003-01-07 Schering Corp Antagonistas do receptor y5 do neuropeptìdeo y de imidazola substituìda
FR2917087B1 (fr) 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209431B (it) * 1980-11-28 1989-07-16 Angeli Inst Spa Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.

Also Published As

Publication number Publication date
KR910000661B1 (ko) 1991-01-31
IT8322110A0 (it) 1983-07-18
CS244141B2 (en) 1986-07-17
PT78935A (de) 1984-08-01
PH21566A (en) 1987-12-11
YU43367B (en) 1989-06-30
PT78935B (de) 1986-10-23
CA1257274A (en) 1989-07-11
SU1322979A3 (ru) 1987-07-07
IL72417A0 (en) 1984-11-30
PL248779A1 (en) 1985-12-03
GB2149395A (en) 1985-06-12
SU1313345A3 (ru) 1987-05-23
NO162857B (no) 1989-11-20
NO842921L (no) 1985-01-21
ES8601910A1 (es) 1985-11-01
AU3080084A (en) 1985-01-24
SG48687G (en) 1987-07-24
DK350084A (da) 1985-01-19
US4649150A (en) 1987-03-10
IT1206498B (it) 1989-04-27
HUT34959A (en) 1985-05-28
ES534376A0 (es) 1985-11-01
CS554284A2 (en) 1985-08-15
EP0131973B1 (en) 1989-08-02
FI842432A0 (fi) 1984-06-15
YU112686A (en) 1987-12-31
FI842432A (fi) 1985-01-19
ES8505962A1 (es) 1985-06-16
HK74287A (en) 1987-10-23
DE3479212D1 (en) 1989-09-07
ES534375A0 (es) 1985-06-16
GR79981B (no) 1984-10-31
KR850001173A (ko) 1985-03-16
JPS6038367A (ja) 1985-02-27
GB2149395B (en) 1986-11-26
YU43701B (en) 1989-10-31
PL254625A1 (en) 1986-05-06
IL72417A (en) 1988-03-31
ATE45149T1 (de) 1989-08-15
ZA845490B (en) 1986-03-26
YU115484A (en) 1986-12-31
DD232696A5 (de) 1986-02-05
AU565292B2 (en) 1987-09-10
PL143732B1 (en) 1988-03-31
HU193292B (en) 1987-09-28
EP0131973A1 (en) 1985-01-23
NZ208920A (en) 1987-03-31
PL143303B1 (en) 1988-02-29
GB8418149D0 (en) 1984-08-22
DK350084D0 (da) 1984-07-17

Similar Documents

Publication Publication Date Title
NO162857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive amidin-derivater av 2-substituert 4-fenylimidazol.
NO159269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske fenylamidiner.